Literature DB >> 16443056

Tetracyclines: nonantibiotic properties and their clinical implications.

Allen N Sapadin1, Raul Fleischmajer.   

Abstract

Tetracyclines are broad-spectrum antibiotics that act as such at the ribosomal level where they interfere with protein synthesis. They were first widely prescribed by dermatologists in the early 1950s when it was discovered that they were effective as a treatment for acne. More recently, biologic actions affecting inflammation, proteolysis, angiogenesis, apoptosis, metal chelation, ionophoresis, and bone metabolism have been researched. The therapeutic effects of tetracycline and its analogues in various diseases have also been investigated. These include rosacea, bullous dermatoses, neutrophilic diseases, pyoderma gangrenosum, sarcoidosis, aortic aneurysms, cancer metastasis, periodontitis, and autoimmune disorders such as rheumatoid arthritis and scleroderma. We review the nonantibiotic properties of tetracycline and its analogues and their potential for clinical application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443056     DOI: 10.1016/j.jaad.2005.10.004

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  173 in total

Review 1.  Rosacea: The cytokine and chemokine network.

Authors:  Peter Arne Gerber; Bettina Alexandra Buhren; Martin Steinhoff; Bernhard Homey
Journal:  J Investig Dermatol Symp Proc       Date:  2011-12

Review 2.  Evaluation of current therapeutic strategies in Behçet's disease.

Authors:  Iliana Alexoudi; Violetta Kapsimali; Aristides Vaiopoulos; Meletios Kanakis; George Vaiopoulos
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

Review 3.  Strategies for Treatment-Resistant Depression: Lessons Learned from Animal Models.

Authors:  Gislaine Zilli Réus; Airam Barbosa de Moura; Laura Araújo Borba; Helena Mendes Abelaira; João Quevedo
Journal:  Mol Neuropsychiatry       Date:  2019-05-21

Review 4.  Rosacea: new and emerging treatments.

Authors:  Farah A Moustafa; Laura F Sandoval; Steven R Feldman
Journal:  Drugs       Date:  2014-09       Impact factor: 9.546

5.  [Antimicrobial peptides, Vitamin D₃ and more. How rosacea may develop].

Authors:  J Schauber
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

6.  Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood.

Authors:  Julia Cazalis; Shin-ichi Tanabe; Guy Gagnon; Timo Sorsa; Daniel Grenier
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

7.  Production of human type II collagen using an efficient baculovirus-silkworm multigene expression system.

Authors:  Qi Qi; Lunguang Yao; Zhisheng Liang; Donghua Yan; Zhuo Li; Yadong Huang; Jingchen Sun
Journal:  Mol Genet Genomics       Date:  2016-09-26       Impact factor: 3.291

8.  Skin communicates what we deeply feel: antibiotic prophylactic treatment to reduce epidermal growth factor receptor inhibitors induced rash in lung cancer (the Pan Canadian rash trial).

Authors:  Oscar Arrieta; Amir Carmona; Maria Teresa de Jesus Vega; Mariana Lopez-Mejia; Andrés F Cardona
Journal:  Ann Transl Med       Date:  2016-08

Review 9.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

10.  A macrophage cell model for selective metalloproteinase inhibitor design.

Authors:  Faith E Jacobsen; Matthew W Buczynski; Edward A Dennis; Seth M Cohen
Journal:  Chembiochem       Date:  2008-09-01       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.